Jade Biosciences (JBIO) Preferred Shares Issued (2021)

Jade Biosciences (JBIO) reported Preferred Shares Issued of $55.5 million for Q2 2021, up 595.59% quarter-over-quarter from $8.0 million in Q1 2021.

Jade Biosciences (JBIO) Preferred Shares Issued (2021) Analysis & Trends

Jade Biosciences has reported Preferred Shares Issued for 1 years, with the latest figure at $55.5 million in Q2 2021.

For the quarter ending Q2 2021, Preferred Shares Issued changed N/A year-over-year to $55.5 million; the trailing twelve-month figure through Dec 2021 stood at $63.5 million (changed N/A YoY), and the FY2021 full-year result was $63.5 million, up 890.36% from the prior year.
Preferred Shares Issued for Q2 2021 stood at $55.5 million, up from $8.0 million in the prior quarter.
The five-year high for Preferred Shares Issued was $55.5 million in Q2 2021, with the low at $8.0 million in Q1 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	-
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Jade Biosciences	973.55 Mn	973.55 Mn	-	-

Download Data